Fluconazole failure in two cases of disseminated candidosis

Scand J Infect Dis. 1995;27(4):421-4. doi: 10.3109/00365549509032746.

Abstract

Amphotericin B has been the standard treatment of disseminated candidosis although the less toxic fluconazole tends to be used more frequently. In a recent report, no significant difference in the efficacy of candidaemia treatment was observed between fluconazole and amphotericin B. However, we report on 2 cases of invasive candidosis where fluconazole failed to eradicate Candida albicans although the isolates were susceptible to fluconazole in vitro. Pulsed-field gel electrophoresis was used to confirm the persistence of the same C. albicans strain after therapy failure in both patients.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use*
  • Candida albicans / drug effects
  • Candida albicans / isolation & purification
  • Candidiasis / drug therapy*
  • Electrophoresis, Gel, Pulsed-Field
  • Female
  • Fluconazole / pharmacology
  • Fluconazole / therapeutic use*
  • Fungemia / drug therapy*
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Treatment Failure

Substances

  • Antifungal Agents
  • Fluconazole